Showing results (1-10 of 751) with videos related to
Sort By:
Pageof 76
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|January 1, 1997
[Minimally differentiated hypoplastic leukemia in two elderly patients]J Tanabe, H Mohri, T OkuboThe Journal of Biological Chemistry|June 28, 1996
Identification of a novel binding site to the integrin alphaIIbbeta3 located in the C-terminal heparin-binding domain of human plasma fibronectinH Mohri, J Tanabe, K Katoh, et al.Peptides|January 1, 1995
Synthetic peptides demonstrate RGD-independent platelet glycoprotein IIb/IIIa recognition site in cell binding domain of human fibronectinH Mohri, J Tanabe, K Katoh, et al.Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|February 1, 1994
[VEPA and ML-Y1 regimen for elderly non-Hodgkin's lymphoma]J Tanabe, H Kanamori, M Matsuzaki, et al.Hematopathology and Molecular Hematology|January 1, 1996
Acquired type 2A von Willebrand disease in chronic myelocytic leukemiaH Mohri, J Tanabe, E Yamazaki, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 1, 1995
Acquired von Willebrand disease associated with multiple myeloma; characterization of an inhibitor to von Willebrand factorH Mohri, J Tanabe, M Ohtsuka, et al.Peptides|January 1, 1996
Novel synthetic peptides from the C-terminal heparin binding domain of fibronectin with heparin binding activityH Mohri, K Katoh, S Motomura, et al.Biochemical and Biophysical Research Communications|November 5, 1997
A synthetic peptide, FN-C/H-V, from the C-terminal heparin-binding domain of fibronectin promotes adhesion of PMA stimulated U937 cellsK Kato, H Mohri, T Tamura, et al.Experimental Cell Research|February 1, 1996
The novel recognition site in the C-terminal heparin-binding domain of fibronectin by integrin alpha 4 beta 1 receptor on HL-60 cellsH Mohri, K Katoh, A Iwamatsu, et al.American Journal of Clinical Pathology|March 1, 1994
Autoimmune antibody in a patient with idiopathic thrombocytopenic purpura reacted to the platelet low molecular weight glycoproteins and activated plateletsY Hashimoto, J Tanabe, H Mohri, et al.Pageof 76